Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.67 |
| ▸ | CA1 | P00915 | 3/20 | 0.67 |
| ▸ | CA2 | P00918 | 3/20 | 0.67 |
| ▸ | CA7 | P43166 | 3/20 | 0.67 |
| ▸ | CA9 | Q16790 | 3/20 | 0.67 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | ESR1 | P03372 | 5/20 | 0.56 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.56 |
| ▸ | TSHR | P16473 | 3/20 | 0.53 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | KDR | P35968 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9724886 | 1.00 | CA12 (0.67) | CA12CA1CA2CA7CA9 | |
| SCHEMBL9437191 | 0.95 | CA12 (0.61) | CA12CA1CA2CA7CA9 | |
| SCHEMBL9437187 | 0.95 | CA12 (0.61) | CA12CA1CA2CA7CA9 | |
| Phenol SCHEMBL3274652 | 0.93 | CA12 (0.59) | CA12CA1CA2CA7CA9 | |
| SCHEMBL1965809 | 0.92 | CA12 (0.53) | CA12CA1CA2CA7CA9 | |
| SCHEMBL4736415 | 0.87 | CA12 (0.48) | CA12CA1CA2CA7CA9 | |
| SCHEMBL6388164 | 0.86 | CA12 (0.59) | CA12CA1CA2CA7CA9 | |
| SCHEMBL6388169 | 0.86 | CA12 (0.59) | CA12CA1CA2CA7CA9 | |
| SCHEMBL8198278 | 0.86 | CA12 (0.62) | CA12CA1CA2CA7CA9 | |
| SCHEMBL8970835 | 0.86 | CA12 (0.62) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 536 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3490525-A1 | SKIN CARE PRODUCTS AND USES THEREOF | Wang, Jonas (US) | 2019-06-05 | — | — | EP | claimed |
| US-20190159991-A1 | SKIN CARE PRODUCTS AND USES THEREOF | WANG, JONAS | 2019-05-30 | — | — | US | claimed |
| EP-2768909-B1 | INK FORMULATION AND MANUFACTURE THEREOF | EndoChoice (US) | 2018-08-01 | — | — | EP | claimed |
| WO-2018022561-A1 | SKIN CARE PRODUCTS AND USES THEREOF | WANG JONAS (US) | 2018-02-01 | — | — | WO | claimed |
| US-20170049735-A1 | BROMFENAC BIOAVAILABILITY | BAUSCH & LOMB PHARMA HOLDINGS CORP. (US) | 2017-02-23 | — | — | US | claimed |
| US-9034087-B2 | Ink formulation and manufacture thereof | ENDOCHOICE, INC. (US) | 2015-05-19 | — | — | US | claimed |
| EP-2768909-A1 | INK FORMULATION AND MANUFACTURE THEREOF | Endochoice (US) | 2014-08-27 | — | — | EP | claimed |
| EP-2765988-A1 | OCULAR COMPOSITION CONTAINING BROMFENAC WITH INCREASED BIOAVAILABILITY | Bausch & Lomb Incorporated (US) | 2014-08-20 | — | — | EP | claimed |
| US-20140182480-A1 | Ink Formulation and Manufacture Thereof | ENDOCHOICE INC. (US) | 2014-07-03 | — | — | US | claimed |
| US-8709142-B2 | Ink formulation and manufacture thereof | ENDOCHOICE, INC. (US) | 2014-04-29 | — | — | US | claimed |
| EP-1076567-A4 | COMPOSITIONS AND METHOD FOR IMMUNIZING POULTRY | MKB INVEST LTD PARTNERSHIP (US) | 2001-12-12 | — | — | EP | claimed |
| EP-1076567-A1 | COMPOSITIONS AND METHOD FOR IMMUNIZING POULTRY | Mkb Investments Limited Partnership (US) | 2001-02-21 | — | — | EP | claimed |
| WO-1999059626-A1 | COMPOSITIONS AND METHOD FOR IMMUNIZING POULTRY | MKB INVESTMENTS LIMITED PARTNERSHIP (US) | 1999-11-25 | — | — | WO | claimed |
| EP-0689418-B1 | DEODORANT ACTIVE-SUBSTANCE COMBINATIONS MADE FROM WOOL-GREASE ACIDS AND PARTIAL GLYCERIDES | SOLVAY ALKALI GMBH (DE) | 1998-09-30 | — | — | EP | claimed |
| EP-0226671-B1 | TITANIUM DIOXIDE SUSPENSION FOR USE IN FILM COATING | CROMPTON & KNOWLES CORPORATION (US) | 1991-04-03 | — | — | EP | claimed |
| US-4833023-A | CONTAINING SOILD PLASTICIZER | MITSUBISHI PAPER MILLS, LTD. (JP) | 1989-05-23 | — | — | US | claimed |
| US-4695452-A | Cosmetic stick | GANNIS PETER M | 1987-09-22 | — | — | US | claimed |
| EP-0226671-A1 | Titanium dioxide suspension for use in film coating | CROMPTON & KNOWLES CORPORATION (US) | 1987-07-01 | — | — | EP | claimed |
| US-4642663-A | 6-tetrahydrofurfurylaminofluoran compound useful as a color former on an heat sensitive recording sheet | HODOGAYA CHEMICAL CO., LTD. (JP) | 1987-02-10 | — | — | US | claimed |
| US-4357258-A | Stable emulsions of p-hydroxybenzoic acid esters and method of preparation | MALLINCKRODT, INC. (US) | 1982-11-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190159991-A1 | SKIN CARE PRODUCTS AND USES THEREOF | CUTA, PROC, GLA | CA12 4229/4885CA1 4691/4885CA2 2261/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.